Cargando…

Cryptotanshinone Attenuated Pathological Cardiac Remodeling In Vivo and In Vitro Experiments

OBJECTIVE: Cardiac remodeling has been demonstrated to be the early stage and common pathway for various types of cardiomyopathy, but no specific treatment has been suggested to prevent its development and progress. This study was aimed at assessing whether Cryptotanshinone (CTS) treatment could eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wen-jing, Yan, Han, Zhou, Zi-ying, Zhang, Nan, Ding, Wen, Liao, Hai-han, Tang, Qi-zhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897919/ https://www.ncbi.nlm.nih.gov/pubmed/36743695 http://dx.doi.org/10.1155/2023/4015199

Ejemplares similares

Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022)

Cardiomyocyte-Specific RIP2 Overexpression Exacerbated Pathologic Remodeling and Contributed to Spontaneous Cardiac Hypertrophy
por: Yang, Jing-jing, et al.
Publicado: (2021)

Research Progress on the Interaction Between Autophagy and Energy Homeostasis in Cardiac Remodeling
por: Ding, Wen, et al.
Publicado: (2020)

Development of cryptotanshinone-loaded pellets for angina chronotherapy: In vitro/in vivo prediction and evaluation()
por: Li, Zhenghua, et al.
Publicado: (2018)

Cardiac fibroblast sub-types in vitro reflect pathological cardiac remodeling in vivo
por: Herum, Kate Møller, et al.
Publicado: (2022)

Cryptotanshinone Attenuates Oxygen-Glucose Deprivation/ Recovery-Induced Injury in an in vitro Model of Neurovascular Unit
por: Zhao, Hongye, et al.
Publicado: (2019)

Cryptotanshinone-Loaded Cerasomes Formulation: In Vitro Drug Release, in Vivo Pharmacokinetics, and in Vivo Efficacy for Topical Therapy of Acne
por: Zuo, Ting, et al.
Publicado: (2016)

Cryptotanshinone inhibits esophageal squamous-cell carcinoma in vitro and in vivo through the suppression of STAT3 activation
por: Ji, Yubin, et al.
Publicado: (2019)

Attenuation of doxorubicin-induced cardiotoxicity by cryptotanshinone detected through association analysis of transcriptomic profiling and KEGG pathway
por: Li, Le, et al.
Publicado: (2020)

Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by regulating TRAF6-ASK1 axis
por: Yen, Jia-Hau, et al.
Publicado: (2022)

Effects and mechanisms of trifluridine alone or in combination with cryptotanshinone in inhibiting malignant biological behavior of gastric cancer
por: Luo, Pan-Quan, et al.
Publicado: (2023)

Cryptotanshinone induces ROS-mediated apoptosis in human gastric cancer cells
por: Liu, Chang, et al.
Publicado: (2017)

Cryptotanshinone attenuates LPS-induced acute lung injury by regulating metabolic reprogramming of macrophage
por: Ye, Zesen, et al.
Publicado: (2023)

Loss of chemerin triggers bone remodeling in vivo and in vitro
por: Han, Long, et al.
Publicado: (2021)

The Roles of Noncardiomyocytes in Cardiac Remodeling
por: Yang, Dan, et al.
Publicado: (2020)

Cryptotanshinone Attenuates Inflammatory Response of Microglial Cells via the Nrf2/HO-1 Pathway
por: Zhou, Yang, et al.
Publicado: (2019)

Ethosomes Loaded with Cryptotanshinone for Acne Treatment through Topical Gel Formulation
por: Yu, Zhenwei, et al.
Publicado: (2016)

Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation
por: Lu, Liang, et al.
Publicado: (2017)

Cryptotanshinone enhances wound healing in type 2 diabetes with modulatory effects on inflammation, angiogenesis and extracellular matrix remodelling
por: Song, Min, et al.
Publicado: (2020)

The Influence of Selected Factors on the Aqueous Cryptotanshinone Solubility
por: Kobryń, Justyna, et al.
Publicado: (2021)

Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway
por: Guo, Huijun, et al.
Publicado: (2022)

Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway
por: Mou, Shan-Qi, et al.
Publicado: (2021)

Cryptotanshinone Attenuates Airway Remodeling by Inhibiting Crosstalk Between Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Transforming Growth Factor Beta 1 Signaling Pathways in Asthma
por: Wang, Chongyang, et al.
Publicado: (2019)

Mixed Medicinal Mushroom Mycelia Attenuates Alzheimer’s Disease Pathologies In Vitro and In Vivo
por: Jeong, Ji Heun, et al.
Publicado: (2023)

Inhibition of activin A receptor signalling attenuates age-related pathological cardiac remodelling
por: Clavere, Nicolas G., et al.
Publicado: (2022)

Cryptotanshinone induces apoptosis of activated hepatic stellate cells via modulating endoplasmic reticulum stress
por: Hou, Xiao-Xue, et al.
Publicado: (2023)

Cryptotanshinone Ameliorates Radiation-Induced Lung Injury in Rats
por: Jiang, Yifang, et al.
Publicado: (2019)

Targeting oncogenic mutations in colorectal cancer using cryptotanshinone
por: Vundavilli, Haswanth, et al.
Publicado: (2021)

Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma
por: Luo, Yi, et al.
Publicado: (2020)

Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload
por: Zhang, Nan, et al.
Publicado: (2021)

Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo
por: Shen, Li, et al.
Publicado: (2017)

CTBP1-AS upregulation is associated with polycystic ovary syndrome and can be effectively downregulated by cryptotanshinone
por: Wen, Mingxiao, et al.
Publicado: (2022)

New Insights Into the Antibacterial Mechanism of Cryptotanshinone, a Representative Diterpenoid Quinone From Salvia miltiorrhiza Bunge
por: Chen, Bo-Chen, et al.
Publicado: (2021)

Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway
por: Liao, Hai-han, et al.
Publicado: (2019)

Cryptotanshinone Suppressed Postmenopausal Osteoporosis by Preventing RANKL-Mediated Osteoclastogenesis against Kidney Injury
por: Yang, Wenjiu, et al.
Publicado: (2022)

Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro
por: He, Jian, et al.
Publicado: (2023)

Cryptotanshinone Alleviates Oxidative Stress and Reduces the Level of Abnormally Aggregated Protein in Caenorhabditis elegans AD Models
por: Cui, Wen-Bo, et al.
Publicado: (2022)

Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature
por: Zhou, Huan, et al.
Publicado: (2019)

Remodelling of adult cardiac tissue subjected to physiological and pathological mechanical load in vitro
por: Pitoulis, Fotios G, et al.
Publicado: (2021)

Genome-Wide Transcriptional Profiling of the Response of Staphylococcus aureus to Cryptotanshinone
por: Feng, Haihua, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4fcoursuolbqgeofetrh5t4nnt